Markets
Canada and Mexico two flags together textile cloth fabric texture
Getty Images
Duties call

How will tariffs impact company profits?

Analysts from Goldman Sachs estimate a modest hit to S&P 500 profits.

On Saturday, President Trump announced that the United States will impose a 25% tariff on imports from Mexico and Canada, and an additional 10% tariff on imports from China. Since then, a deal has been reached with Mexico to delay tariffs by one month, although at the time of writing no such reprieve is in sight for the northern neighbor.

The original announcement would have seen tariffs go into effect on Tuesday for goods arriving from the three countries that America buys most from — a trio of nations that are collectively responsible for $1.25 trillion worth of imports last year (up to November).

That’s bad news if you spend a lot of cash on avocado on toast (about 90% of America’s avo supply comes from Mexico). It also likely means a direct impact on the profits of America’s largest companies.

Indeed, Goldman Sachs’ researchers, led by David Kostin, estimated in a new note published this morning that (emphasis ours):

“...every 5pp increase in the US tariff rate would reduce S&P 500 EPS by roughly 1-2%. As a result, if sustained, the tariffs announced this weekend would reduce our S&P 500 EPS forecasts by roughly 2-3%, not taking into account any additional impact from major financial conditions tightening or a larger-than-expected effect of policy uncertainty on corporate or consumer behavior.”

So, at face value, we’re potentially talking about profits mechanically falling 2% to 3% in aggregate, which is the simple part of the explanation as to why the SPDR S&P 500 ETF is down 1.6% in premarket trading, with automotive stocks like General Motors , Ford, and Volkswagen among the stocks getting hit the hardest. T

The harder stuff to foresee? Second-order impacts. Those could include, but are not limited to: the impact of tariffs on rising policy uncertainty, manufacturing relocation, the potential impact of retaliations, the downstream effect on inflation — and therefore interest rates — and the “release valve” effect of a stronger US dollar.

EPU Index
Sherwood News

Indeed, the US Economic Policy Uncertainty Index, a measure of how much major US newspapers are referencing economic uncertainty, spiked to a reading of 502 on January 31, with the average of the last 30 days at its highest level since the pandemic.

More Markets

See all Markets
markets

Canopy rallies after CEO stock purchase

Canopy Growth rallied on Wednesday after its CEO, Luc Mongeau, disclosed an unplanned stock purchase on Tuesday.

Mongeau, who joined Canopy from Mars in January, bought 27,469 shares at CA$1.84. The buy is worth about US$36,259.

It has been a tumultuous time for cannabis stocks, as the market in Canada (where Canopy is located) stagnates and cannabis reform in the US has yet to move forward.

markets

Robinhood, new S&P 500 leader, the subject of favorable analyst chatter

Robinhood Markets briefly touched a new all-time intraday high in early trading after the newly minted — and now top-performing — member of the the S&P 500 received some favorable write-ups from Wall Street analysts.

(Robinhood Markets Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions. I own stock as part of my compensation.)

Piper Sandler analysts highlighted momentum in the company’s prediction markets business thanks to the rollout of contracts on college and profession football, noting that the event contracts business was running at a $200 million annualized rate so far in September. They raised their price target on the shares to $140 from $120.

“Prediction Markets (aka event contracts) present significant upside opportunity for Robinhood,” Piper Sandler’s Patrick Moley wrote.

Elsewhere, Citi analysts raised their Q3 and full-year 2025 estimates and upped their price target on the shares to $135, but kept a “neutral” rating on the stock.

“While HOOD continues to see solid momentum across the platform, we believe the stock is pricing in much of the growth potential in our view. Given current valuations and where we are in the retail cycle (closer to the highs than the lows from an activity perspective from our viewpoint), we prefer to wait for a more reasonable entry point at present.”

The stock has clearly had a heck of a run.

Through yesterday’s close, Robinhood was up nearly 240% in 2025. Since it was added to the S&P 500 on Monday, it’s now the top performer among the blue chips, trouncing previous leaders Seagate Technology Holdings and Palantir.

markets

UniQure surges after encouraging trial results for Huntington’s treatment

UniQure rose more than 150% in early trading Wednesday after it released trial results that showed its experimental gene therapy for Huntington’s disease slowed its progression by 75% after three years.

The treatment, AMT-130, is a one-time treatment for Huntington’s, a genetic brain disease that degrades cognitive function and muscle control. There is currently no cure for the disease.

UniQure said it plans to submit the treatment for approval to the Food and Drug Administration in the first quarter of 2026, meaning it could become available to patients later that year. The company currently makes nearly all of its revenue from gene therapies that treat hemophilia.

Halo of the sun

A tiny UK company is showing how easy it is to get an (undeserved?) Nvidia halo effect

Step 1: join a free Nvidia program. Step 2: watch stock go up. Step 3: watch stock go down.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.